A team of researchers, led by scientists at Dartmouth Medical School and Dartmouth College, have identified and tested a gene that dramatically alters both muscle metabolism and performance. The researchers say that this finding could someday lead to treatment for muscle diseases, including helping the elderly who suffer from muscle deterioration and improving muscle performance in endurance athletes.
Normal aging of breast tissue lessens breast cancer risk, reports a new study by Mayo Clinic Cancer Center researchers published in the Nov. 15 issue of the Journal of the National Cancer Institute.
For the first time, researchers have successfully used a rabbit’s cells to grow heart-valve-shaped tissue inside the animal’s body, according to research reported at the American Heart Association’s Scientific Sessions 2006.
Stronger quadriceps muscles in the legs can help protect against cartilage loss behind the kneecap, according to Mayo Clinic researchers presenting preliminary study data at the American College of Rheumatology Annual Meeting on Nov. 15.
Individuals who have higher levels of a fatty acid known as docosahexaenoic acid in their blood may have a significantly lower risk of developing dementia and Alzheimer’s disease, according to a report in the November issue of Archives of Neurology, one of the JAMA/Archives journals.
New research shows that patients who are HIV positive may be at an increased risk for developing chronic obstructive pulmonary disease (COPD).
Investigators are presenting more than 380 abstracts on preliminary findings in the diagnosis and treatment of allergic diseases at the ACAAI Annual Meeting in Philadelphia, Nov. 9-15. Following are highlights of some key investigations on allergic rhinitis and ocular allergies.
AstraZeneca announced a new program that provides significant savings to Medicare Part D beneficiaries who may have difficulty affording their medicines. Beginning Nov. 15, people who qualify and enroll will be able to go to their participating local pharmacy and immediately receive savings on AstraZeneca products, including NEXIUM? (esomeprazole), CRESTOR? (rosuvastatin), SEROQUEL? (quetiapine fumarate), TOPROL XL? (metoprolol succinate) and ARIMIDEX? (anastrozole). This is a unique offering in comparison to other patient assistance programs because it gives people convenient savings on their medicines at the pharmacy counter.
A new UCLA study has found that physicians discuss cost and aspects of obtaining newly prescribed medications only about one-third of the time during patient/doctor interactions.
Potentially blinding blood vessel growth in the cornea resulting from eye injury or even surgery can be reduced by more than 50 percent with a new manmade protein, researchers say.